Investors Face September Deadline in Park Ha Biological Technology Lawsuit

The lawsuit, spearheaded by the Rosen Law Firm, alleges that Park Ha misled shareholders by failing to disclose a fraudulent stock promotion scheme. According to the complaint, this scheme relied on social media misinformation and individuals impersonating financial professionals to artificially inflate the company's stock price. Plaintiffs claim the firm’s IPO was intentionally engineered with an exceptionally low public float to facilitate this activity.

Investors who purchased securities during the specified period may be eligible for compensation through a contingency fee arrangement, meaning no out-of-pocket costs are required to participate. While the deadline to move the court for lead plaintiff status is September 28, 2026, investors are not required to serve in that capacity to potentially participate in a future recovery. No class has been certified at this time, and shareholders retain the right to select their own legal representation or remain absent from the litigation.